233 related articles for article (PubMed ID: 26776394)
1. [Negative symptoms in schizophrenia: psychotherapeutic approaches].
Azorin JM; Adida M; Belzeaux R; Pringuey D; Micoulaud Franchi JA; Simon N; Cermolacce M; Kaladjian A; Fakra E
Encephale; 2015 Dec; 41(6 Suppl 1):6S57-60. PubMed ID: 26776394
[TBL] [Abstract][Full Text] [Related]
2. [Negative symptoms in schizophrenia: new pharmacological approaches].
Lodovighi MA; Palomba A; Belzeaux R; Adida M; Azorin JM
Encephale; 2015 Dec; 41(6 Suppl 1):6S41-9. PubMed ID: 26776392
[TBL] [Abstract][Full Text] [Related]
3. The Psychology of Schizophrenia: Implications for Biological and Psychotherapeutic Treatments.
Dewan MJ
J Nerv Ment Dis; 2016 Aug; 204(8):564-9. PubMed ID: 27479611
[TBL] [Abstract][Full Text] [Related]
4. Recognizing primary vs secondary negative symptoms and apathy vs expression domains.
Kirkpatrick B
J Clin Psychiatry; 2014 Apr; 75(4):e09. PubMed ID: 24813410
[TBL] [Abstract][Full Text] [Related]
5. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
[TBL] [Abstract][Full Text] [Related]
6. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
[TBL] [Abstract][Full Text] [Related]
7. [The clinic of apathy in schizophrenia: a critical review of the issue].
Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
[TBL] [Abstract][Full Text] [Related]
8. Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders.
Foussias G; Agid O; Fervaha G; Remington G
Eur Neuropsychopharmacol; 2014 May; 24(5):693-709. PubMed ID: 24275699
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
[TBL] [Abstract][Full Text] [Related]
10. [Use of antidepressants in the treatment of negative symptoms of schizophrenia].
Palomba A; Lodovighi MA; Belzeaux R; Adida M; Azorin JM
Encephale; 2015 Dec; 41(6 Suppl 1):6S36-40. PubMed ID: 26776391
[TBL] [Abstract][Full Text] [Related]
11. Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.
Favrod J; Nguyen A; Chaix J; Pellet J; Frobert L; Fankhauser C; Ismailaj A; Brana A; Tamic G; Suter C; Rexhaj S; Golay P; Bonsack C
Psychother Psychosom; 2019; 88(2):84-95. PubMed ID: 30783071
[TBL] [Abstract][Full Text] [Related]
12. [Negative symptoms in schizophrenia - overview and practical implications].
Klaus F; Dorsaz O; Kaiser S
Rev Med Suisse; 2018 Sep; 14(619):1660-1664. PubMed ID: 30230774
[TBL] [Abstract][Full Text] [Related]
13. [Negative symptoms: which antipsychotics?].
Maurel M; Belzeaux R; Adida M; Azorin JM
Encephale; 2015 Dec; 41(6 Suppl 1):6S32-5. PubMed ID: 26776390
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of negative symptom dimensions of schizophrenia - Current developments and implications for treatment.
Bègue I; Kaiser S; Kirschner M
Neurosci Biobehav Rev; 2020 Sep; 116():74-88. PubMed ID: 32533996
[TBL] [Abstract][Full Text] [Related]
15. O tempora, O mores: directions in research on the psychotherapeutic treatment of schizophrenia.
Docherty JP
Schizophr Bull; 1984; 10(4):621-3. PubMed ID: 6151249
[TBL] [Abstract][Full Text] [Related]
16. [Incidence of the deficit form in refractory schizophrenia].
Samuelian JC
Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
[TBL] [Abstract][Full Text] [Related]
17. Clinical management of negative symptoms of schizophrenia: An update.
Tsapakis EM; Dimopoulou T; Tarazi FI
Pharmacol Ther; 2015 Sep; 153():135-47. PubMed ID: 26116809
[TBL] [Abstract][Full Text] [Related]
18. [Early intervention in increased risk for schizophrenic illnesses. Multimodal psychotherapy--antipsychotic drugs only in treatment failure].
Wieneke A; Bechdolf A; Schultze-Lutter F
MMW Fortschr Med; 2000 Mar; 142(10):30-2. PubMed ID: 10748600
[TBL] [Abstract][Full Text] [Related]
19. Sandro Morselli: schizophrenic solitude, suicide, and psychotherapy.
Maltsberger JT; Pompili M; Tatarelli R
Suicide Life Threat Behav; 2006 Oct; 36(5):591-600. PubMed ID: 17087638
[No Abstract] [Full Text] [Related]
20. Evolving perspectives on individual psychotherapy for schizophrenia.
Fenton WS
Schizophr Bull; 2000; 26(1):47-72. PubMed ID: 10755669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
